FDA Tackles Neurological Disorders in Five Guidances, Flags Patient Input

The FDA released five guidances on treatments for a variety of neurological disorders including Duchenne muscular dystrophy and Alzheimer’s disease, offering suggestions for trial designs and methods of measuring effectiveness.
Source: Drug Industry Daily